The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin

Tascioglu F., Colak O., Armagan O., Alatas O., Oner C.

RHEUMATOLOGY INTERNATIONAL, vol.26, no.1, pp.21-29, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 1
  • Publication Date: 2005
  • Doi Number: 10.1007/s00296-004-0496-3
  • Journal Name: RHEUMATOLOGY INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.21-29
  • Keywords: glucocorticoids, osteoporosis, rheumatoid arthritis, BONE-MINERAL DENSITY, POSTMENOPAUSAL WOMEN, VERTEBRAL FRACTURE, DOUBLE-BLIND, CORTICOSTEROID-THERAPY, PREVENTION, MASS, HIP, METABOLISM, MARKERS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

The purpose of this study was to assess the effects of alendronate and intranasal salmon calcitonin (sCT) treatments on bone mineral density and bone turnover in postmenopausal osteoporotic women with rheumatoid arthritis (RA) receiving low-dose glucocorticoids.